Healthcare provider profile · identity verified

Robert Bailey, MD

Family Practice · JAMESTOWN, NY · NPI 1023428612

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	496	148
Levothyroxine Sodium	Levothyroxine Sodium	449	121
Lisinopril	Lisinopril	409	115
Omeprazole	Omeprazole	278	76
Amlodipine Besylate	Amlodipine Besylate	266	80
Metoprolol Succinate	Metoprolol Succinate	262	80
Metformin Hcl	Metformin Hcl	234	69
Losartan Potassium	Losartan Potassium	229	72
Pantoprazole Sodium	Pantoprazole Sodium	228	68
Hydrochlorothiazide	Hydrochlorothiazide	212	69
Albuterol Sulfate Hfa	Albuterol Sulfate	185	58
Famotidine	Famotidine	185	60
Simvastatin	Simvastatin	164	49
Gabapentin	Gabapentin	159	51
Allopurinol	Allopurinol	158	45
Tamsulosin Hcl	Tamsulosin Hcl	156	41
Potassium Chloride	Potassium Chloride	141	44
Metoprolol Tartrate	Metoprolol Tartrate	124	36
Pravastatin Sodium	Pravastatin Sodium	123	38
Rosuvastatin Calcium	Rosuvastatin Calcium	120	35
Furosemide	Furosemide	117	41
Fluticasone Propionate	Fluticasone Propionate	105	35
Clopidogrel	Clopidogrel Bisulfate	100	31
Sertraline Hcl	Sertraline Hcl	99	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	91	21
Eliquis	Apixaban	85	28
Glipizide	Glipizide	81	21
Glimepiride	Glimepiride	79	22
Ozempic	Semaglutide	79	20
Jardiance	Empagliflozin	77	23
Citalopram Hbr	Citalopram Hydrobromide	73	23
Atenolol	Atenolol	72	23
Trazodone Hcl	Trazodone Hcl	71	24
Warfarin Sodium	Warfarin Sodium	67	15
Donepezil Hcl	Donepezil Hcl	66	16
Duloxetine Hcl	Duloxetine Hcl	63	23
Prednisone	Prednisone	57	40
Meloxicam	Meloxicam	56	25
Fluoxetine Hcl	Fluoxetine Hcl	54	14
Lovastatin	Lovastatin	49	14
Triamcinolone Acetonide	Triamcinolone Acetonide	49	26
Clonidine Hcl	Clonidine Hcl	48	15
Escitalopram Oxalate	Escitalopram Oxalate	47	13
Spironolactone	Spironolactone	47	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	14
Montelukast Sodium	Montelukast Sodium	45	16
Ezetimibe	Ezetimibe	44	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	36
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	17
Hydralazine Hcl	Hydralazine Hcl	39	14
Doxycycline Hyclate	Doxycycline Hyclate	38	22
Xarelto	Rivaroxaban	38	suppressed
Alendronate Sodium	Alendronate Sodium	37	suppressed
Synthroid	Levothyroxine Sodium	37	suppressed
Januvia	Sitagliptin Phosphate	36	11
Spiriva Respimat	Tiotropium Bromide	36	suppressed
Carvedilol	Carvedilol	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	19
Enalapril Maleate	Enalapril Maleate	35	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	13
Arnuity Ellipta	Fluticasone Furoate	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Finasteride	Finasteride	31	suppressed
Nystatin	Nystatin	31	18
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	21
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	30	30
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Bumetanide	Bumetanide	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Terazosin Hcl	Terazosin Hcl	28	suppressed
Valsartan	Valsartan	28	suppressed
Azithromycin	Azithromycin	27	26
Sildenafil Citrate	Sildenafil Citrate	26	suppressed
Baclofen	Baclofen	25	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Risperidone	Risperidone	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Folic Acid	Folic Acid	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	11
Celecoxib	Celecoxib	22	11
Atrovent Hfa	Ipratropium Bromide	21	suppressed
Colchicine	Colchicine	21	suppressed
Amoxicillin	Amoxicillin	20	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Roflumilast	Roflumilast	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	17
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Anastrozole	Anastrozole	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Febuxostat	Febuxostat	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Cephalexin	Cephalexin	14	suppressed
Eplerenone	Eplerenone	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Linzess	Linaclotide	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Testosterone	Testosterone	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Ofloxacin	Ofloxacin	11	suppressed
Primidone	Primidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error